Scorecard
| Current Price | Overvalued | |
| Yield (%) – Higher is better Current Yield: 2.29% Industry Average: 3.21% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 4.68% Industry Average: 6.41% | ||
| Returns (%) – Higher is better Returns: 45.47% Industry Average: 10.29% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR:64.81% Industry Average: 51.51% | ||
JOHNSON & JOHNSON
(XNYS:JNJ)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 227.38 | $ -3.27 |
Dividend
Annual Dividend | Annual Yield |
$ 5.20 | 2.29 % |
Dividend Streak | 5 Year Average |
64 year(s) | 2.85 % |
Fair Price
Current Stock price is considered: Overvalued
| Current Price ● $ 227.38 |
| Less Than $169.23 | $169.23 – $196.77 | More Than $196.77 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
1 Year | 3 Year | 5 Year |
4.68 % | 4.92 % | 5.25 % |
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 4.19 | $ 4.45 | $ 4.70 | $ 4.91 | $ 5.14 |
Price Return
1 Year | 5 Year | CAGR 5 Years |
$ 71.07 45.47 % | $ 64.65 | 6.92 % |